Literature DB >> 16380914

The Y deletion gr/gr and susceptibility to testicular germ cell tumor.

Katherine L Nathanson1, Peter A Kanetsky, Rachel Hawes, David J Vaughn, Richard Letrero, Kathy Tucker, Michael Friedlander, Kelly-Anne Phillips, David Hogg, Michael A S Jewett, Radka Lohynska, Gedske Daugaard, Stéphane Richard, Agnés Chompret, Catherine Bonaïti-Pellié, Axel Heidenreich, Edith Olah, Lajos Geczi, Istvan Bodrogi, Wilma J Ormiston, Peter A Daly, J Wolter Oosterhuis, Ad J M Gillis, Leendert H J Looijenga, Parry Guilford, Sophie D Fosså, Ketil Heimdal, Sergei A Tjulandin, Ludmila Liubchenko, Hans Stoll, Walter Weber, Matthew Rudd, Robert Huddart, Gillian P Crockford, David Forman, D Timothy Oliver, Lawrence Einhorn, Barbara L Weber, Joan Kramer, Mary McMaster, Mark H Greene, Malcolm Pike, Victoria Cortessis, Chu Chen, Stephen M Schwartz, D Timothy Bishop, Douglas F Easton, Michael R Stratton, Elizabeth A Rapley.   

Abstract

Testicular germ cell tumor (TGCT) is the most common cancer in young men. Despite a considerable familial component to TGCT risk, no genetic change that confers increased risk has been substantiated to date. The human Y chromosome carries a number of genes specifically involved in male germ cell development, and deletion of the AZFc region at Yq11 is the most common known genetic cause of infertility. Recently, a 1.6-Mb deletion of the Y chromosome that removes part of the AZFc region--known as the "gr/gr" deletion--has been associated with infertility. In epidemiological studies, male infertility has shown an association with TGCT that is out of proportion with what can be explained by tumor effects. Thus, we hypothesized that the gr/gr deletion may be associated with TGCT. Using logistic modeling, we analyzed this deletion in a large series of TGCT cases with and without a family history of TGCT. The gr/gr deletion was present in 3.0% (13/431) of TGCT cases with a family history, 2% (28/1,376) of TGCT cases without a family history, and 1.3% (33/2,599) of unaffected males. Presence of the gr/gr deletion was associated with a twofold increased risk of TGCT (adjusted odds ratio [aOR] 2.1; 95% confidence interval [CI] 1.3-3.6; P = .005) and a threefold increased risk of TGCT among patients with a positive family history (aOR 3.2; 95% CI 1.5-6.7; P = .0027). The gr/gr deletion was more strongly associated with seminoma (aOR 3.0; 95% CI 1.6-5.4; P = .0004) than with nonseminoma TGCT (aOR 1.5; 95% CI 0.72-3.0; P = .29). These data indicate that the Y microdeletion gr/gr is a rare, low-penetrance allele that confers susceptibility to TGCT.

Entities:  

Mesh:

Year:  2005        PMID: 16380914      PMCID: PMC1285161          DOI: 10.1086/498455

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  42 in total

1.  The DAZ gene cluster on the human Y chromosome arose from an autosomal gene that was transposed, repeatedly amplified and pruned.

Authors:  R Saxena; L G Brown; T Hawkins; R K Alagappan; H Skaletsky; M P Reeve; R Reijo; S Rozen; M B Dinulos; C M Disteche; D C Page
Journal:  Nat Genet       Date:  1996-11       Impact factor: 38.330

2.  The epidemiology of testicular cancer in young adults.

Authors:  D Schottenfeld; M E Warshauer; S Sherlock; A G Zauber; M Leder; R Payne
Journal:  Am J Epidemiol       Date:  1980-08       Impact factor: 4.897

3.  Risks of testicular cancer and cryptorchidism in relation to socio-economic status and related factors: case-control studies in Denmark.

Authors:  H Møller; N E Skakkebaek
Journal:  Int J Cancer       Date:  1996-05-03       Impact factor: 7.396

4.  Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A population-based study.

Authors:  T Westergaard; J H Olsen; M Frisch; N Kroman; J W Nielsen; M Melbye
Journal:  Int J Cancer       Date:  1996-05-29       Impact factor: 7.396

5.  Case-control study of whether subfertility in men is familial.

Authors:  R Lilford; A M Jones; D T Bishop; J Thornton; R Mueller
Journal:  BMJ       Date:  1994-09-03

6.  Testicular cancer in nine northern European countries.

Authors:  H O Adami; R Bergström; M Möhner; W Zatoński; H Storm; A Ekbom; S Tretli; L Teppo; H Ziegler; M Rahu
Journal:  Int J Cancer       Date:  1994-10-01       Impact factor: 7.396

7.  Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene.

Authors:  R Reijo; T Y Lee; P Salo; R Alagappan; L G Brown; M Rosenberg; S Rozen; T Jaffe; D Straus; O Hovatta
Journal:  Nat Genet       Date:  1995-08       Impact factor: 38.330

8.  Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis.

Authors:  D Forman; R T Oliver; A R Brett; S G Marsh; J H Moses; J G Bodmer; C E Chilvers; M C Pike
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

9.  Familial testicular cancer in Norway and southern Sweden.

Authors:  K Heimdal; H Olsson; S Tretli; P Flodgren; A L Børresen; S D Fossa
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

10.  Familial risk in testicular cancer as a clue to a heritable and environmental aetiology.

Authors:  K Hemminki; X Li
Journal:  Br J Cancer       Date:  2004-05-04       Impact factor: 7.640

View more
  80 in total

Review 1.  Local signalling environments and human male infertility: what we can learn from mouse models.

Authors:  Roopa L Nalam; Martin M Matzuk
Journal:  Expert Rev Mol Med       Date:  2010-05-11       Impact factor: 5.600

2.  [Research in urologic university clinics. Assessment of current status and perspectives].

Authors:  K Miller; H Krause
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

3.  Asymptomatic Sertoli cell tumour diagnosed during azoospermia work-up.

Authors:  Hakan Ozturk; Musa Saracoglu; Tarik Zengin; Oya Nermin Sivrikoz; Hüseyin Serhat Kerman; Saban Adakan
Journal:  Asian J Androl       Date:  2013-10-14       Impact factor: 3.285

4.  Intratubular transplantation as a strategy for establishing animal models of testicular germ cell tumours.

Authors:  Yunmin Li; Tatsuo Kido; Jinping Luo; Michiko Fukuda; Ina Dobrinski; Yun-Fai Chris Lau
Journal:  Int J Exp Pathol       Date:  2008-10       Impact factor: 1.925

Review 5.  Testicular germ cell tumours: predisposition genes and the male germ cell niche.

Authors:  Duncan Gilbert; Elizabeth Rapley; Janet Shipley
Journal:  Nat Rev Cancer       Date:  2011-03-17       Impact factor: 60.716

6.  Selection Has Countered High Mutability to Preserve the Ancestral Copy Number of Y Chromosome Amplicons in Diverse Human Lineages.

Authors:  Levi S Teitz; Tatyana Pyntikova; Helen Skaletsky; David C Page
Journal:  Am J Hum Genet       Date:  2018-08-02       Impact factor: 11.025

Review 7.  Etiologic factors in testicular germ-cell tumors.

Authors:  Katherine A McGlynn; Michael B Cook
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

8.  LINE-1 methylation is inherited in familial testicular cancer kindreds.

Authors:  Lisa Mirabello; Sharon A Savage; Larissa Korde; Shahinaz M Gadalla; Mark H Greene
Journal:  BMC Med Genet       Date:  2010-05-17       Impact factor: 2.103

Review 9.  The association risk of male subfertility and testicular cancer: a systematic review.

Authors:  Xiaoning Peng; Xiaomin Zeng; Sihua Peng; Defeng Deng; Jian Zhang
Journal:  PLoS One       Date:  2009-05-18       Impact factor: 3.240

10.  Clinical and genetic aspects of testicular germ cell tumours.

Authors:  Martijn F Lutke Holzik; Rolf H Sijmons; Josette Ehm Hoekstra-Weebers; Dirk T Sleijfer; Harald J Hoekstra
Journal:  Hered Cancer Clin Pract       Date:  2008-02-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.